Chicago Jury Orders Abbott Laboratories to Pay $70 Million in Premature Infant Formula Case

Date:

Share post:

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Sahajanand Medical Technologies Secures Health Canada Class IV Licence for Supraflex Cruz™️ Stent System, Entering Canadian Market

Sahajanand Medical Technologies (SMT), a leading global medical device company, announced that it has received a Class IV...

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to...

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for sevabertinib, an oral,...

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...